EDSA compared with HRTX: revenue, margins and what each company keeps, and the suppliers and customers both name

EDSAEdesa Biotech, Inc.

Mkt capRevenueRevenue

HRTXHeron Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

EDSAEdesa Biotech, Inc.

HRTXHeron Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

EDSAEdesa Biotech, Inc.

2.46▼−4.28%· post 2.48· delayed

Mkt cap$24.8MRevenue—Revenue—

HRTXHeron Therapeutics, Inc.

0.28▲+1.37%· post 0.30· delayed

After hoursNov 2 '26delayed

Mkt cap$52.7MRevenue$38MQ2 FY26Revenue$155MFY25

Compare

After hoursNov 2 '26delayed

EDSAEdesa Biotech, Inc.

HRTXHeron Therapeutics, Inc.

2.46▼−4.28%post 2.48delayed

Price

0.28▲+1.37%post 0.30delayed

$24.8M

Mkt cap

$52.7M

—

Revenue

$38MQ2 FY26

—

Revenue

$155MFY25

EDSA2.46▼−4.28%vsHRTX0.28▲+1.37%After hoursNov 2 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

EDSA: latest quarter not drawable. HRTX: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: EDSA, HRTX.

Role chip = supplier or customerSource: SEC EDGAR

Price

rebased to 0%

EDSA, solidHRTX, dashed